Chris Willey, PhD, of University of Alabama at Birmingham’s Departments of Radiation Oncology shares how 3D human microtumors are being established as a human-based diagnostic screening method to optimize chemotherapeutic regimens.

• Learn why 3D microtumors may be the closes resemblance to human tumors ex vivo
• Discover how this model offers a quick, seven-day assay to evaluate potential chemotherapeutic drugs
• Explore how these 3D human models can be used for further investigations, including gene and protein analysis